GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » EV Biologics Inc (OTCPK:YECO) » Definitions » Effective Interest Rate on Debt %

EV Biologics (EV Biologics) Effective Interest Rate on Debt % : 47.00% (As of Dec. 2017)


View and export this data going back to 2015. Start your Free Trial

What is EV Biologics Effective Interest Rate on Debt %?

Effective Interest Rate on Debt % is the usage rate that a borrower actually pays on a debt. It is calculated as the positive value of Interest Expense divided by its average total debt. Total debt equals to Long-Term Debt & Capital Lease Obligation plus Short-Term Debt & Capital Lease Obligation. EV Biologics's annualized positive value of Interest Expense for the quarter that ended in Dec. 2017 was $3.95 Mil. EV Biologics's average total debt for the quarter that ended in Dec. 2017 was $8.41 Mil. Therefore, EV Biologics's annualized Effective Interest Rate on Debt % for the quarter that ended in Dec. 2017 was 47.00%.


EV Biologics Effective Interest Rate on Debt % Historical Data

The historical data trend for EV Biologics's Effective Interest Rate on Debt % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

EV Biologics Effective Interest Rate on Debt % Chart

EV Biologics Annual Data
Trend Jun13 Jun14 Jun15 Jun16 Jun17
Effective Interest Rate on Debt %
10.59 11.67 11.71 9.15 6.55

EV Biologics Quarterly Data
Jun13 Sep13 Dec13 Mar14 Jun14 Sep14 Dec14 Mar15 Jun15 Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Jun17 Dec17
Effective Interest Rate on Debt % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 10.90 8.04 43.53 - 47.00

Competitive Comparison of EV Biologics's Effective Interest Rate on Debt %

For the Biotechnology subindustry, EV Biologics's Effective Interest Rate on Debt %, along with its competitors' market caps and Effective Interest Rate on Debt % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


EV Biologics's Effective Interest Rate on Debt % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, EV Biologics's Effective Interest Rate on Debt % distribution charts can be found below:

* The bar in red indicates where EV Biologics's Effective Interest Rate on Debt % falls into.



EV Biologics Effective Interest Rate on Debt % Calculation

EV Biologics's annualized Effective Interest Rate on Debt % for the fiscal year that ended in Jun. 2017 is calculated as

Effective Interest Rate on Debt %
=-1  *  Interest Expense/( (Total Debt  (A: Jun. 2016 )+Total Debt  (A: Jun. 2017 ))/ count )
=-1  *  -0.659/( (9.765+10.347)/ 2 )
=-1  *  -0.659/10.056
=6.55 %

where

Total Debt  (A: Jun. 2016 )
=Long-Term Debt & Capital Lease Obligation + Short-Term Debt & Capital Lease Obligation
=0.029 + 9.736
=9.765

Total Debt  (A: Jun. 2017 )
=Long-Term Debt & Capital Lease Obligation + Short-Term Debt & Capital Lease Obligation
=0 + 10.347
=10.347

EV Biologics's annualized Effective Interest Rate on Debt % for the quarter that ended in Dec. 2017 is calculated as

Effective Interest Rate on Debt %
=-1  *  Interest Expense/( (Total Debt  (Q: Jun. 2017 )+Total Debt  (Q: Dec. 2017 ))/ count )
=-1  *  -3.952/( (10.347+6.469)/ 2 )
=-1  *  -3.952/8.408
=47.00 %

where

Total Debt  (Q: Jun. 2017 )
=Long-Term Debt & Capital Lease Obligation + Short-Term Debt & Capital Lease Obligation
=0 + 10.347
=10.347

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Effective Interest Rate on Debt %, the Interest Expense of the last fiscal year and the average total debt over the fiscal year are used. In calculating the quarterly data, the Interest Expense data used here is four times the quarterly (Dec. 2017) interest expense data. Effective Interest Rate on Debt % is displayed in the 30-year financial page.


EV Biologics  (OTCPK:YECO) Effective Interest Rate on Debt % Explanation

Effective Interest Rate on Debt % measures the usage rate that a borrower actually pays on a debt.


EV Biologics Effective Interest Rate on Debt % Related Terms

Thank you for viewing the detailed overview of EV Biologics's Effective Interest Rate on Debt % provided by GuruFocus.com. Please click on the following links to see related term pages.


EV Biologics (EV Biologics) Business Description

Industry
Traded in Other Exchanges
N/A
Address
1621 Central Avenue, Cheyenne, WY, USA, 82001
EV Biologics Inc is developing the extraordinary biological properties of extracellular vesicles (EVs) to create the next generation of diagnostic modalities and safe, effective biotherapeutics to improve outcomes of serious clinical conditions, increase natural longevity and transform lives.
Executives
Daniel S Mckinney director, 10 percent owner, officer: CEO TWO IFC, 19TH FLOOR, 8 FINANCE STREET, CENTRAL, HONG KONG F4 000000
Michael W Harlan director C/O WASTE CONNECTIONS, INC., 610 APPLEWOOD CRESCENT, SUITE 200, VAUGHAN A6 L4K 0C3

EV Biologics (EV Biologics) Headlines

From GuruFocus

EV Biologics Announces NFT Dividend

By ACCESSWIRE ACCESSWIRE 07-14-2021

EV Biologics Launches Excyte with $100 million Valuation

By ACCESSWIRE ACCESSWIRE 08-15-2022

EV Biologics Updates on Excyte Subsidiary Funding

By ACCESSWIRE ACCESSWIRE 01-03-2023

EV Biologics NFT Dividend Information

By ACCESSWIRE ACCESSWIRE 08-09-2021

EV Biologics Updates Shareholders on Name and Symbol Change

By ACCESSWIRE ACCESSWIRE 05-19-2021

EV Biologics Signs Listing Agreement With INX

By ACCESSWIRE ACCESSWIRE 11-11-2021